Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
UNCY	UNICYCIVE THERAPEUTICS INC	$82.15M	-278.40%	-61.80%	-134.77%	156.50%	1.48	1.64	N/A	N/A	N/A
ERAS	ERASCA INC	$419.27M	-36.60%	-31.10%	-35.35%	-36.10%	0.18	12.35	N/A	N/A	N/A
ATAI	ATAI LIFE SCIENCES NV	$422.71M	-102.40%	-77.60%	-87.19%	-89.70%	0.29	4.07	100.00%	-7,997.20%	-7,828.56%
VYNE	VYNE THERAPEUTICS INC	$14.98M	-71.90%	-59.00%	-95.60%	-119.70%	0.28	4.47	100.00%	-6,974.50%	-6,973.88%
INMB	INMUNE BIO INC	$178.72M	-119.40%	-89.40%	-136.56%	700.80%	0.27	2.64	100.00%	-81,592.00%	-81,592.00%
ALGS	ALIGOS THERAPEUTICS INC	$47.15M	-104.00%	-51.00%	-53.88%	-160.90%	0.29	7.56	100.00%	-1,628.70%	-2,170.92%
AVXL	ANAVEX LIFE SCIENCES CORP	$685.54M	-40.90%	-36.40%	-47.45%	404.80%	0.17	6.74	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$5.66B	-92.10%	-15.80%	-14.55%	-9.90%	4.91	9.66	98.50%	-63.90%	-51.99%
YMAB	Y-MABS THERAPEUTICS INC	$213.29M	-30.60%	-22.70%	-32.92%	-115.20%	0.26	4.77	81.80%	-31.80%	-34.78%
RLAY	RELAY THERAPEUTICS INC	$552.05M	-44.20%	-39.50%	-43.73%	-46.50%	0.11	19.96	100.00%	-4,341.50%	-4,341.53%
HLVX	HILLEVAX INC	$92.76M	-61.30%	-49.00%	-60.31%	-85.30%	0.19	25.32	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$421.89M	-38.10%	-35.50%	-25.63%	734.90%	0.08	14.80	N/A	N/A	N/A
IFRX	INFLARX NV	$53.11M	-64.00%	-53.30%	-63.13%	-103.10%	0.24	5.28	-2,293.60%	-34,466.40%	-34,445.08%
MNPR	MONOPAR THERAPEUTICS	$204.98M	-55.40%	-51.50%	-30.92%	-301.30%	0.03	36.92	N/A	N/A	N/A
ADCT	ADC THERAPEUTICS SA	$355.06M	N/A	-45.60%	-46.44%	-76.50%	-2.14	4.46	92.70%	-197.60%	-131.54%
CGEN	COMPUGEN LTD	$146.85M	-24.50%	-12.20%	-10.16%	-41.60%	1.02	5.09	70.20%	-51.30%	-34.78%
CLNN	CLENE INC	$36.83M	N/A	-93.40%	-176.24%	-113.50%	-6.09	1.36	78.90%	-8,306.00%	-7,326.57%
AXSM	AXSOME THERAPEUTICS INC	$5.13B	-363.80%	-48.90%	-76.62%	-153.90%	10.22	2.03	91.50%	-64.40%	-62.54%
FBIO	FORTRESS BIOTECH INC	$54.70M	-241.60%	-34.10%	-25.89%	-49.20%	6.54	1.72	67.40%	-87.80%	-46.78%
ASMB	ASSEMBLY BIOSCIENCES INC	$128.69M	-131.80%	-36.80%	-75.57%	-101.30%	2.65	2.05	N/A	N/A	N/A
CMMB	CHEMOMAB THERAPEUTICS LTD	$22.64M	-106.70%	-82.20%	-126.75%	-206.10%	0.23	5.33	N/A	N/A	N/A
JAZZ	JAZZ PHARMACEUTICALS PLC	$6.69B	11.90%	4.10%	5.69%	7.50%	1.76	3.38	88.80%	11.90%	14.44%
AVIR	ATEA PHARMACEUTICALS INC	$270.43M	-31.30%	-29.30%	-33.14%	-42.80%	0.07	19.94	N/A	N/A	N/A
ABEO	ABEONA THERAPEUTICS INC	$315.13M	-86.50%	-38.20%	-49.07%	-40.40%	1.40	4.90	N/A	N/A	N/A
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$676.09M	-15.00%	-13.00%	-12.73%	-25.20%	0.11	10.62	95.00%	-42.70%	-38.25%
PHIO	PHIO PHARMACEUTICALS CORP	$10.89M	-105.70%	-89.20%	-55.59%	862.90%	0.10	10.58	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$432.15M	N/A	N/A	N/A	N/A	0.17	6.47	N/A	N/A	N/A
ABUS	ARBUTUS BIOPHARMA CORP	$676.09M	-75.50%	-55.80%	-78.35%	-92.50%	0.48	6.01	100.00%	-1,195.90%	-1,193.97%
IVVD	INVIVYD INC	$95.01M	-165.20%	-99.70%	-263.57%	2,600.20%	0.92	1.53	93.30%	-389.00%	-389.00%
BNTX	BIONTECH SE	$25.62B	-4.00%	-3.50%	-3.71%	-7.80%	0.12	10.18	79.40%	-27.90%	-26.56%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$106.74M	N/A	N/A	N/A	N/A	-1.88	0.41	N/A	N/A	N/A
NRSN	NEUROSENSE THERAPEUTICS LTD	$55.28M	N/A	-461.70%	-395.28%	388.00%	0.77	2.21	N/A	N/A	N/A
LQDA	LIQUIDIA CORP	$1.21B	-170.30%	-57.60%	-67.82%	-92.40%	3.58	2.93	58.10%	-903.80%	-800.35%
IBRX	IMMUNITYBIO INC	$2.71B	N/A	-109.40%	-103.57%	-24.00%	-1.51	2.22	99.80%	-1,310.30%	-844.37%
NRXP	NRX PHARMACEUTICALS INC	$59.47M	N/A	-460.00%	95.82%	166.60%	-1.30	0.22	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$57.87M	-270.30%	-137.70%	-245.11%	911.10%	4.78	1.98	100.00%	-429.40%	-429.42%
ITRM	ITERUM THERAPEUTICS PLC	$39.64M	N/A	-83.80%	-67.27%	-138.40%	-13.91	3.73	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$3.56B	-20.00%	-6.90%	-5.74%	-4.30%	2.03	4.02	81.80%	-11.10%	-7.35%
ACTU	ACTUATE THERAPEUTICS INC	$169.71M	N/A	-339.70%	541.38%	279.10%	-1.88	0.46	N/A	N/A	N/A
NNNN	ANBIO BIOTECHNOLOGY	$1.23B	14.80%	13.70%	13.80%	44.90%	0.10	10.71	71.90%	29.00%	28.99%
VERV	VERVE THERAPEUTICS INC	$549.12M	-35.80%	-27.60%	-32.14%	-33.90%	0.30	9.84	100.00%	-303.60%	-303.09%
LYEL	LYELL IMMUNOPHARMA INC	$143.83M	-73.70%	-61.00%	-86.10%	-75.40%	0.28	7.49	100.00%	-576,762.10%	-576,762.07%
IKT	INHIBIKASE THERAPEUTICS INC	$138.28M	-79.00%	-70.90%	-42.63%	-281.10%	0.10	11.01	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$245.29M	N/A	-15.00%	-18.36%	-22.70%	-0.04	10.96	100.00%	-22,362.10%	-22,394.12%
ITOS	ITEOS THERAPEUTICS INC	$389.24M	-21.40%	-18.50%	-18.98%	-23.40%	0.17	14.13	100.00%	-373.70%	-336.72%
LCTX	LINEAGE CELL THERAPEUTICS INC	$184.97M	-22.20%	-15.30%	-16.43%	5,088.20%	0.43	3.82	97.20%	-169.60%	-169.57%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$29.38M	-281.10%	-111.20%	-123.10%	-229.30%	0.93	0.82	28.20%	-15,698.00%	-15,273.15%
TLSA	TIZIANA LIFE SCIENCES LTD	$172.77M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$265.79M	-8.30%	-6.80%	-10.53%	-16.50%	0.24	3.93	94.30%	-22.00%	-27.63%
MREO	MEREO BIOPHARMA GROUP PLC	$438.84M	-69.30%	-57.30%	-77.77%	4,192.90%	0.14	8.92	N/A	N/A	N/A
ATYR	ATYR PHARMA INC	$462.82M	-86.90%	-64.80%	-73.26%	-74.00%	0.30	7.80	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-88.10%	-45.20%	-59.66%	3,668.10%	0.78	1.75	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$49.37M	-36.90%	-32.60%	-38.79%	-570.40%	0.61	14.31	N/A	N/A	N/A
ENSC	ENSYSCE BIOSCIENCES INC	$4.91M	-176.20%	-121.80%	-237.48%	-683.50%	0.62	2.50	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$12.47M	N/A	-313.30%	-2,794.16%	384.30%	12.45	0.97	100.00%	-3,716.10%	-3,688.55%
VRCA	VERRICA PHARMACEUTICALS INC	$57.62M	N/A	-145.60%	-443.55%	-170.80%	-3.27	1.34	71.60%	-919.20%	-789.72%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$335.75M	-27.40%	-19.00%	-29.66%	-276.90%	0.42	5.64	100.00%	-47.50%	-58.30%
XNCR	XENCOR INC	$654.06M	-31.90%	-22.60%	-20.82%	-18.20%	0.41	5.89	100.00%	-163.20%	-133.60%
BBIO	BRIDGEBIO PHARMA INC	$7.55B	N/A	-82.00%	-75.23%	-26.00%	-1.53	4.57	95.40%	-524.20%	-430.76%
MDWD	MEDIWOUND LTD	$220.50M	-74.10%	-30.90%	-43.05%	-76.30%	1.21	2.15	14.40%	-110.50%	-105.70%
CVAC	CUREVAC NV	$1.25B	29.60%	24.40%	30.83%	84.20%	0.15	7.65	87.60%	34.50%	40.09%
CLSD	CLEARSIDE BIOMEDICAL INC	$62.17M	N/A	-114.20%	-205.35%	-53.50%	-1.43	3.19	72.30%	-2,148.60%	-2,098.74%
TRVI	TREVI THERAPEUTICS INC	$619.63M	-58.40%	-52.50%	-47.31%	-76.10%	0.08	15.38	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$557.54M	-43.60%	-29.10%	-27.22%	-36.40%	1.04	8.07	100.00%	-267.50%	-261.86%
EPIX	ESSA PHARMA INC	$74.13M	-23.50%	-22.90%	-25.06%	-96.80%	0.02	67.17	N/A	N/A	N/A
SLN	SILENCE THERAPEUTICS PLC	$251.49M	-2,380.90%	-34.20%	-41.31%	-86.70%	-0.64	8.81	67.40%	-256.30%	-245.91%
CDTX	CIDARA THERAPEUTICS INC	$296.23M	-132.70%	-98.60%	-128.03%	831.10%	0.35	3.87	100.00%	-60,589.70%	-60,589.74%
PBM	PSYENCE BIOMEDICAL LTD	$2.23M	N/A	-583.50%	465.76%	5,423.00%	-1.10	0.09	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$137.58M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A
ANAB	ANAPTYSBIO INC	$685.15M	-282.50%	-30.80%	-37.19%	-21.40%	11.41	8.25	100.00%	-125.70%	-125.66%
LXRX	LEXICON PHARMACEUTICALS INC	$243.69M	-103.20%	-55.00%	-88.16%	-60.30%	1.42	2.22	98.00%	-568.00%	-528.10%
CCCC	C4 THERAPEUTICS INC	$119.29M	-45.90%	-29.00%	-37.01%	-32.90%	0.64	5.70	100.00%	-259.60%	-259.27%
JBIO	JADE BIOSCIENCES INC	$5.60M	-60.00%	-54.30%	-65.11%	-103.60%	0.03	32.01	N/A	N/A	N/A
BIVI	BIOVIE INC	$21.16M	-102.80%	-80.00%	-82.42%	1,054.90%	0.13	9.32	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$270.44M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
ELAB	PMGC HOLDINGS INC	$2.86M	-99.40%	-75.60%	-70.55%	-1,676.80%	0.09	8.97	72.50%	1,050.70%	933.15%
VCEL	VERICEL CORP	$2.15B	1.10%	0.70%	0.97%	1.00%	0.44	5.01	72.50%	1.20%	1.57%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$234.24M	-121.00%	-101.30%	-73.00%	-243.60%	0.07	12.32	29.80%	-1,313.90%	-1,313.87%
INSM	INSMED INC	$17.98B	-447.00%	-52.70%	-59.08%	-45.80%	17.18	5.86	76.50%	-265.90%	-242.45%
ALZN	ALZAMEND NEURO INC	$2.38M	-504.20%	-149.10%	-121.98%	316.10%	0.21	5.44	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$14.69B	-70.50%	-57.90%	-66.51%	-84.70%	0.12	10.63	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$4.00B	-762.80%	-45.70%	-53.80%	-81.10%	11.80	3.30	89.60%	-127.10%	-108.04%
TECX	TECTONIC THERAPEUTIC INC	$408.74M	-30.90%	-28.30%	-19.44%	1,185.10%	0.05	22.92	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$816.24M	-23.70%	-22.60%	-24.78%	-29.70%	0.05	23.09	N/A	N/A	N/A
HOTH	HOTH THERAPEUTICS INC	$17.17M	-109.20%	-100.20%	-83.39%	6,121.60%	0.07	15.08	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$611.10M	N/A	N/A	N/A	N/A	0.02	47.43	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$146.16M	-51.50%	-37.80%	-47.47%	-37.20%	0.38	8.82	100.00%	-1,318.90%	-1,318.93%
ANIX	ANIXA BIOSCIENCES INC	$107.59M	-64.10%	-60.40%	-80.41%	-72.00%	0.13	8.89	N/A	N/A	N/A
PTGX	PROTAGONIST THERAPEUTICS INC	$3.49B	9.20%	8.30%	8.07%	12.30%	0.08	17.26	100.00%	27.00%	27.47%
GNLX	GENELUX CORP	$115.47M	-93.00%	-74.20%	-94.30%	-115.30%	0.31	4.68	N/A	N/A	N/A
MGNX	MACROGENICS INC	$95.90M	-59.80%	-23.50%	-32.40%	-79.80%	1.84	3.28	89.90%	-36.20%	-35.57%
ONCO	ONCONETIX INC	$2.47M	-2,162.10%	-136.60%	-1,178.61%	1,019.50%	3.57	0.17	47.40%	-2,986.30%	-2,899.46%
ALLR	ALLARITY THERAPEUTICS INC	$12.11M	-151.70%	-92.70%	-124.13%	364.90%	0.59	2.66	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$9.45M	N/A	-83.80%	-188.53%	-28.10%	-1.43	1.48	-12.20%	-2,163.20%	-1,325.43%
OMER	OMEROS CORP	$199.21M	N/A	-51.80%	-87.53%	-20.40%	-2.10	1.16	N/A	N/A	N/A
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.27B	-32.60%	-29.20%	-24.10%	1,904.80%	0.05	19.98	100.00%	-397.50%	-397.45%
GOVX	GEOVAX LABS INC	$15.65M	-512.00%	-286.60%	-309.93%	2,565.60%	0.37	3.62	N/A	N/A	N/A
ORKA	ORUKA THERAPEUTICS INC	$470.25M	-27.80%	-25.60%	-21.23%	-52.50%	0.03	30.03	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$7.84M	N/A	-90.10%	2,785.82%	-226.00%	-4.07	0.07	100.00%	-7,160.80%	-6,904.18%
NRIX	NURIX THERAPEUTICS INC	$909.49M	-47.50%	-36.10%	-39.66%	-50.10%	0.28	6.26	100.00%	-369.40%	-369.08%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #1 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 62, which is 38 points higher than the biotech industry average of 24.

AUPH passed 20 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 52.9% over the past year, overperforming other biotech stocks by 129 percentage points.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 67, which is 43 points higher than the biotech industry average of 24.

EXEL passed 22 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 89.39% over the past year, overperforming other biotech stocks by 166 percentage points.

Exelixis has an average 1 year price target of $39.94, a downside of -3.97% from Exelixis's current stock price of $41.59.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Exelixis, 31.25% have issued a Strong Buy rating, 18.75% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 73, which is 49 points higher than the biotech industry average of 24.

CPRX passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 53.49% over the past year, overperforming other biotech stocks by 130 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.50, an upside of 38.12% from Catalyst Pharmaceuticals's current stock price of $23.53.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Catalyst Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.58%, which is 5 percentage points higher than the biotech industry average of 1.63%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.02%, which is the same as the biotech industry average of 1.63%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.87%, which is the same as the biotech industry average of 1.63%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.4% in the last day, and down -1.07% over the last week. Biorestorative Therapies was the among the top losers in the biotechnology industry, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the biotech industry by 77 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the biotech industry by 87 percentage points.

3. United Therapeutics (NASDAQ:UTHR)

United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -1.47% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

53.31% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 99.94% over the next year.

2.39% of biotech stocks have a Zen Rating of A (Strong Buy), 4.56% of biotech stocks are rated B (Buy), 35.57% are rated C (Hold), 36.66% are rated D (Sell), and 20.82% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -108.97x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)

2. Exelixis (NASDAQ:EXEL)

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. United Therapeutics (NASDAQ:UTHR)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.